{"id":60770,"date":"2025-02-12T04:03:26","date_gmt":"2025-02-12T03:03:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"modified":"2025-02-12T04:03:26","modified_gmt":"2025-02-12T03:03:26","slug":"oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","title":{"rendered":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference"},"content":{"rendered":"<div>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/ADCs?src=hash\" target=\"_blank\">#ADCs<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Foqory.com%2F&amp;esheet=54204578&amp;newsitemid=20250211204384&amp;lan=en-US&amp;anchor=Oqory&amp;index=1&amp;md5=7f2971107f27456a4091f6629c94aae7\" rel=\"nofollow\" shape=\"rect\">Oqory<\/a>, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer\u2019s 35<sup>th<\/sup> Annual Healthcare Life Sciences Conference.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/5\/OQORY-Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/5\/OQORY-Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/21\/OQORY-Logo.jpg\"><\/a><\/p>\n<p>\nDetails are as follows:<\/p>\n<p>\n<b>Date: <\/b>Wednesday, February 12, 2025<\/p>\n<p>\n<b>Time: <\/b>12:40 PM ET<\/p>\n<p>\n<b>Webcast link for conference participants:<\/b><br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwsw.com%252Fwebcast%252Foppenheimer39%252Foqo%252F2580248%26data%3D05%257C02%257C%257C1447b1b302eb4a3fbfa008dd4a149a8b%257C2eaa3fcad5054a4baab091ceeea8d9f1%257C0%257C0%257C638748174552954244%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3Dn4IZB5MbFGRcd6MyTqaXCFO8WHar2GtRd4XlwBmExlg%253D%26reserved%3D0&amp;esheet=54204578&amp;newsitemid=20250211204384&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwsw.com%2Fwebcast%2Foppenheimer39%2Foqo%2F2580248&amp;index=2&amp;md5=be78d3f3c12bb53c8ed0ee8392688b6e\" rel=\"nofollow\" shape=\"rect\"><b>https:\/\/wsw.com\/webcast\/oppenheimer39\/oqo\/2580248<\/b><\/a><\/p>\n<p>\n<b>About Oqory, Inc.<\/b><\/p>\n<p>\nOqory, Inc. is an innovator in the field of ADCs with expertise in advancing targeted cancer therapies. The Company\u2019s pipeline includes multiple ADC programs, with two currently in clinical development and several next-generation ADCs in preclinical stages. These programs are designed to address critical unmet needs in indications such as breast cancer, non-small cell lung cancer, small cell lung cancer, multiple myeloma, and other metastatic solid tumors. Powered by a proprietary ADC platform, Oqory is focused on delivering therapies that improve outcomes for patients with cancer.<\/p>\n<p>\nOqory is based in San Diego, California.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMichael King<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x6d;&#x6b;&#x69;&#x6e;&#x67;&#x40;&#x6f;&#x71;&#x6f;&#x72;&#x79;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x6d;&#x6b;&#x69;&#x6e;&#x67;&#64;&#111;&#113;&#111;ry&#46;&#x63;&#x6f;&#x6d;<\/a><br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.oqory.com&amp;esheet=54204578&amp;newsitemid=20250211204384&amp;lan=en-US&amp;anchor=www.oqory.com&amp;index=3&amp;md5=7d8a296e9abfc99665cfa802f13289aa\" rel=\"nofollow\" shape=\"rect\">www.oqory.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#ADCs&#8212;Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer\u2019s 35th Annual Healthcare Life Sciences Conference. Details are as follows: Date: Wednesday, February 12, 2025 Time: 12:40 PM ET Webcast link &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60770","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#ADCs&#8212;Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer\u2019s 35th Annual Healthcare Life Sciences Conference. Details are as follows: Date: Wednesday, February 12, 2025 Time: 12:40 PM ET Webcast link ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-12T03:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference\",\"datePublished\":\"2025-02-12T03:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"},\"wordCount\":183,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250211204384\\\/en\\\/2379570\\\/22\\\/OQORY-Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\",\"name\":\"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250211204384\\\/en\\\/2379570\\\/22\\\/OQORY-Logo.jpg\",\"datePublished\":\"2025-02-12T03:03:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250211204384\\\/en\\\/2379570\\\/22\\\/OQORY-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250211204384\\\/en\\\/2379570\\\/22\\\/OQORY-Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend","og_description":"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#ADCs&#8212;Oqory, Inc., a private biopharmaceutical company dedicated to developing next-generation antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Michael King, Chief Executive Officer, will present data at Oppenheimer\u2019s 35th Annual Healthcare Life Sciences Conference. Details are as follows: Date: Wednesday, February 12, 2025 Time: 12:40 PM ET Webcast link ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","og_site_name":"Pharma Trend","article_published_time":"2025-02-12T03:03:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference","datePublished":"2025-02-12T03:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"wordCount":183,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","url":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","name":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg","datePublished":"2025-02-12T03:03:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250211204384\/en\/2379570\/22\/OQORY-Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/oqory-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60770"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60770\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}